On the positive side, order inflows surged 42% YoY to ₹13,400 crore, taking the order backlog to ₹2.04 lakh crore, about 7.2 times FY25 sales.
Brokerages dividedHong Kong-based brokerage firm CLSA maintained an ‘Underperform’ rating with a price target of ₹198. It highlighted that Q1 execution rose just 4% YoY, missing consensus expectations, despite hopes of a turnaround following two years of backlog growth. The stock currently trades at 45x FY26CL price-to-earnings.
In contrast, Nuvama Institutional Equities retained a ‘Buy’ rating, citing the strong momentum in fresh thermal power orders.
It believes BHEL could benefit from a near-monopoly (90%+ market share) in the segment, and may bag another 17GW of orders over the next 2-3 years.
However, Nuvama trimmed its FY26E/FY27E EPS estimates by 15%/5%, lowering its price target to ₹335 (from ₹360 earlier), factoring in execution delays.Nuvama expects EPS to grow from ₹1.5 in FY25 to ₹13.4 by FY27E, backed by a strong order book (80% power mix) and a pipeline of 25-30GW over the next 18-36 months.
Key factors to monitor
– Timely execution of the existing backlog
– Growth in non-thermal segments such as railways, defence, and hydrogen
– Commissioning of legacy projects
– Pace of execution of new thermal power projects (TPPs) won in the last 18 months, expected to be delivered by FY27
Of the 19 analysts that have coverage on BHEL, eight of them continue to have a ‘Sell’ rating on the stock, three have a ‘Hold’ recommendation, while other eight have a ‘Buy’ rating.
Shares of BHEL are off the day’s high and are trading with losses of 4.70% at ₹228.56. The stock has fallen 11% in the last one month.